Biological and Pharmaceutical Bulletin · 2001 · 52 citations · 21 references
MedicineBiochemistryPharmacologyCancer PharmacologyEnzymologyMolecular OncologyEnzyme InhibitionTopoisomerase InhibitorsDna Topoisomerase I InhibitionDna Topoisomerase Ii InhibitionHydroxyl Group ReplacementTopoisomerase ActivityTopoisomerase I InhibitorsTopoisomerase Ii Inhibitors
The substitution of gallic acid at the 3 position of (-)-epigallocatechin-3-O-gallate (EGCG) increased the inhibition against topoisomerase I from calf thymus gland and topoisomerase II from human placenta, and the substitution of a hydroxyl group at the 3' position increased the inhibition against the topoisomerase I. These results suggested that the 3 and 3' positions of the EGCG molecule play important roles in the process of inhibition of topoisomerases I and II. EGCG showed strong inhibition against topoisomerases I from wheat germ, calf thymus gland and Vero cells, and showed weak or no inhibition against topoisomerases I from carcinoma cells such as A549, HeLa and COLO 201 cells. EGCG differentially inhibited the topoisomerases I from different sources.
21
Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II
K M Tewey, Thomas C. Rowe, Liu Yang et al. · Science · 1984 · 1.5K citations